• 免費註冊
  • 加入官方line@
  • 加入FB粉絲團

台股 » 個股 » 健亞 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

健亞

(4130)
可現股當沖
  • 股價
    23.90
  • 漲跌
    ▼0.05
  • 漲幅
    -0.21%
  • 成交量
    335張
  • 產業
    上櫃 生技醫療類股

  • 151人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
健亞 (4130)籌碼相關－凱基-三重 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效，來找出真正獲利的贏家所在券商分點，進而追蹤此贏家所操作的股票與軌跡。

股票投資新手教室：一秒知道是否上對大戶列車

凱基-三重 券商分點個股進出

凱基-三重 券商分點全部個股操作績效/獲利分析

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/1700.00125.2525.20-1254-0.39%
2025/01/16124.9500.0025.3012250.44%
2025/01/15424.411124.5424.85-7187-3.73%
2025/01/1400.000.122.9522.95-0.1104-0.10%
2025/01/0700.001020.8420.75-1084-11.84%
2024/12/2700.000.121.2521.15-0.191-0.07%
2024/12/2500.00022.8520.700930.00%
2024/12/1600.00221.2521.20-296-2.07%
2024/11/20022.2500.0021.9501020.00%
2024/10/010.922.9000.0023.000.91780.50%
2024/08/12222.6000.0022.5522240.89%
2024/08/09522.6100.0022.5552242.22%
2024/08/06121.5500.0021.3512240.45%
2024/08/0500.004521.7121.65-45221-20.31%
2024/08/024523.0400.0022.904521321.10%
2024/07/16224.1000.0024.2022050.97%
2024/07/1100.005224.1124.05-52205-25.32%
2024/07/1000.00624.2024.30-6207-2.90%
2024/07/0800.00224.7024.60-2204-0.98%
2024/07/031024.7500.0024.75102064.83%
2024/07/01225.0000.0024.8022050.98%
2024/06/271824.9400.0024.70182018.95%
2024/06/26224.60424.8024.65-2195-1.02%
2024/06/25424.5000.0024.4541922.07%
2024/06/2400.00024.5024.5501920.00%
2024/06/21224.4000.0024.4521911.05%
2024/06/1800.00124.6524.60-1189-0.53%
2024/06/172224.8000.0024.802219011.52%
2024/06/1300.004124.3524.35-41188-21.76%
2024/06/121724.3900.0024.30171898.96%
2024/06/112424.54024.3524.552418912.65%
2024/05/30623.9500.0024.0062003.00%
2024/05/29224.0000.0024.1022010.99%
2024/05/2800.001024.1024.25-10205-4.86%
2024/05/24124.0000.0024.0012010.50%
2024/05/2300.00324.0023.95-3204-1.47%
2024/05/1000.00023.8523.8502290.00%
2024/05/0300.00024.1024.0502200.00%
2024/04/0800.002025.0025.05-20211-9.45%
2024/04/0200.00024.9025.1002130.00%
2024/03/28025.3500.0025.0502240.00%
2024/03/26024.8800.0024.7002260.00%
2024/03/25025.2300.0025.0002250.00%
2024/03/18224.8500.0025.0022320.86%
2024/03/13025.3500.0025.1502360.00%
2024/03/11025.351.425.0625.10-1.4237-0.59%
2024/03/0700.001026.0025.70-10244-4.09%
2024/03/06025.6000.0025.7502470.00%
2024/03/05225.9000.0025.7522460.81%
2024/03/04226.0000.0026.0022510.79%
2024/02/2700.00725.8025.80-7272-2.57%
2024/02/26025.6500.0025.8002740.00%
2024/02/23225.601325.6025.60-11273-4.03%
2024/02/22226.1000.0026.1022710.74%
2024/02/2100.00625.6025.60-6259-2.31%
2024/02/1900.005725.5425.50-57259-21.93%
2024/02/1600.002025.5025.60-20257-7.78%
新藥研發 浩鼎子公司抗癌新藥申請一期臨床 健亞明年完成試驗Anue鉅亨－2022/09/12
...詳全文
健亞轉投資浩宇超音波D針具追蹤系統 獲美台上市許可UDN聯合新聞網－2022/05/09
健亞（4130）今（9）日宣布，轉投資浩宇生醫公司開發的NAVIRFA（納維爾）超音波3D手術針具追蹤系統，雙雙取得美、......詳全文
健亞轉拓資浩宇NaviFUS®產品 首獲研究用途設備訂單UDN聯合新聞網－2021/03/15
健亞（4130）今（15）日宣布，轉投資的浩宇生醫，下半年將取得肝癌治療產品NAVIRFA®之美國510（k）及台灣二類......詳全文
健亞 相關文章